Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

ID#: NCT03933696

Age: 55 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: April 01, 2019

End Date: September 01, 2022

Contact Information:
Christoph Buettner, MD, PhD
212-241-3425
Barbara Plitnick, RN
518-276-7166
Summary: To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).
Eligibility:

Inclusion Criteria:

- Mild cognitive impairment

- Mild Alzheimer's Disease with an MMSE score of >19 or Clinical Dementia Rating of 0.5 or 1.

- Sleep Disturbance

- Live at home

Exclusion Criteria:

- Blindness

- insulin-dependent diabetes patients

- macular degeneration

- severe sleep apnea
Find a Clinical Trial